{"id":"https://openalex.org/W4399122002","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.tps618","title":"Abemaciclib dose escalation to maintain intensity (ADE-MI).","display_name":"Abemaciclib dose escalation to maintain intensity (ADE-MI).","alternate_titles":[],"publication_year":2024,"publication_date":"2024-05-29","ids":{"openalex":"https://openalex.org/W4399122002","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.tps618"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.tps618","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.tps618","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.tps618","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.TPS618","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4399122002"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.TPS618","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017803605","display_name":"Kevin Prescott","orcid":"https://orcid.org/0000-0002-7867-3980","observed_orcids":["https://orcid.org/0000-0002-7867-3980"]},"institutions":[{"id":"https://openalex.org/I4210125096","display_name":"University of Illinois Hospital & Health Sciences System","ror":"https://ror.org/03jhe7195","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210125096"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Prescott","raw_affiliation_strings":["University of Illinois Hospital & Health Sciences System, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois Hospital & Health Sciences System, Chicago, IL","institution_ids":["https://openalex.org/I4210125096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082772699","display_name":"VK Gadi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"VK Gadi","raw_affiliation_strings":["University of Illinois Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois Chicago, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035708719","display_name":"Oana Cristina Danciu","orcid":"https://orcid.org/0000-0003-4487-9136","observed_orcids":["https://orcid.org/0000-0003-4487-9136"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oana Cristina Danciu","raw_affiliation_strings":["University of Illinois at Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois at Chicago, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075253555","display_name":"Kent F. Hoskins","orcid":"https://orcid.org/0000-0001-8712-0299","observed_orcids":["https://orcid.org/0000-0001-8712-0299"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kent Hoskins","raw_affiliation_strings":["University of Illinois Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois Chicago, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014674961","display_name":"Abiola Falilat Ibraheem","orcid":"https://orcid.org/0000-0002-6593-7908","observed_orcids":["https://orcid.org/0000-0002-6593-7908"]},"institutions":[{"id":"https://openalex.org/I4210125096","display_name":"University of Illinois Hospital & Health Sciences System","ror":"https://ror.org/03jhe7195","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210125096"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abiola Falilat Ibraheem","raw_affiliation_strings":["University of Illinois Hospital & Health Sciences System, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois Hospital & Health Sciences System, Chicago, IL","institution_ids":["https://openalex.org/I4210125096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031162096","display_name":"Jovonne Owens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jovonne Owens","raw_affiliation_strings":["University of Illinois Chicago College of Pharmacy, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois Chicago College of Pharmacy, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042210553","display_name":"Zhengjia Chen","orcid":"https://orcid.org/0000-0002-6301-4931","observed_orcids":["https://orcid.org/0000-0002-6301-4931"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhengjia Chen","raw_affiliation_strings":["University of Illinois Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois Chicago, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"16_suppl","first_page":"TPS618","last_page":"TPS618"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abemaciclib","display_name":"abemaciclib","score":1.0},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9110000133514404},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.9739999771118164},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.7839999794960022},{"id":"https://openalex.org/keywords/dose-interruption","display_name":"dose interruption","score":0.4569999873638153},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.734000027179718},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.8709999918937683},{"id":"https://openalex.org/keywords/hr-her2-breast-cancer","display_name":"hormone receptor-positive HER2-negative breast cancer","score":0.8889999985694885},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.8759999871253967},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.8569999933242798},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.7409999966621399},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6710000038146973},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9679999947547913},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.9240000247955322}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8579001426696777},{"id":"https://openalex.org/C2776056953","wikidata":"https://www.wikidata.org/wiki/Q1182511","display_name":"De-escalation","level":2,"score":0.5733662843704224},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3403400182723999},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3247820734977722}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.16_suppl.tps618","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.tps618","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.tps618","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.TPS618","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.tps618","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.tps618","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.tps618","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.TPS618","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4399122002.pdf","grobid_xml":"https://content.openalex.org/works/W4399122002.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7129535428","https://openalex.org/W7167497331","https://openalex.org/W4410808859","https://openalex.org/W4415280865","https://openalex.org/W4411291238","https://openalex.org/W4411290036","https://openalex.org/W4410795694","https://openalex.org/W7151051798","https://openalex.org/W3010409414","https://openalex.org/W7205005123"],"abstract_inverted_index":{"TPS618":[0],"Background:":[1],"Abemaciclib":[2],"is":[3,10,33,78,179,244],"a":[4,132,140,162,180,269,276,294],"an":[5],"oral":[6],"CDK4/6":[7],"inhibitor":[8],"that":[9,142,155],"FDA-approved":[11],"as":[12,131],"adjuvant":[13,91,121,201],"therapy":[14],"for":[15,115,187,198],"certain":[16],"patients":[17,53,104,188,250,273],"with":[18,25,54,62,145,189,200,205,308],"early-stage":[19,191],"HR+HER2-":[20,192],"breast":[21,193],"cancer":[22,194],"in":[23,72,203,314],"combination":[24,204],"endocrine":[26,206],"therapy.":[27,92,122,207],"The":[28,238,341,348],"major":[29],"toxicity":[30],"of":[31,43,52,112,120,134,158,164,171,220,225,234,241,249,256,261,267,271,278,291,306,318,322],"abemaciclib":[32,57,159,202,221,257],"diarrhea,":[34,327],"which":[35],"often":[36],"occurs":[37],"within":[38],"the":[39,73,108,116,153,169,218,223,230,247,252,264,284,288,304,315,352],"first":[40,316,349],"6-8":[41],"days":[42,307],"treatment":[44,58,74,199],"initiation.":[45],"Across":[46],"several":[47],"registrational":[48],"trials,":[49],"roughly":[50,63],"25%":[51],"diarrhea":[55,69,97,130,313],"from":[56,83],"required":[59,65],"dose":[60,66,111,126,135,160,219,233,255],"interruptions":[61],"20%":[64],"reductions.":[67],"Because":[68],"happens":[70],"early":[71],"course,":[75],"one":[76],"concern":[77],"this":[79,242],"might":[80],"dissuade":[81],"people":[82],"continuing":[84],"on":[85,107,251,346,351],"or":[86,174,325],"being":[87],"fully":[88],"adherent":[89],"to":[90,95,105,128,245,282,333,344],"Incorporating":[93],"strategies":[94],"minimize":[96],"may":[98],"improve":[99],"adherence":[100],"and":[101,138,330,332],"permit":[102],"more":[103],"stay":[106],"target":[109],"recommended":[110,232,254],"150mg":[113,235],"BID":[114,236],"full":[117],"2":[118],"years":[119],"Our":[123],"trial-in-progress":[124],"evaluates":[125],"escalation":[127],"address":[129],"cause":[133],"interruptions,":[136],"reductions,":[137],"discontinuations,":[139],"strategy":[141],"has":[143],"worked":[144],"other":[146],"therapeutic":[147],"agents.":[148],"Specifically,":[149],"our":[150],"study":[151,243,353],"tests":[152],"hypothesis":[154],"gradual":[156],"up-titration":[157],"over":[161,222],"course":[163,224],"4":[165,226],"weeks":[166,227],"will":[167,211,215,274],"decrease":[168],"rate":[170],"grade":[172,311,323],"3":[173,259,324],"worse":[175],"diarrhea.":[176],"Methods:":[177],"This":[178],"post-marketing,":[181],"single":[182],"arm,":[183],"phase":[184],"IV":[185],"trial":[186,342,358],"high-risk":[190],"who":[195],"are":[196,302],"eligible":[197],"Fifty":[208],"(50)":[209],"subjects":[210],"be":[212],"enrolled.":[213],"Patients":[214],"gradually":[216],"up-titrate":[217],"before":[228],"reaching":[229],"FDA":[231,253],"(Table).":[237],"primary":[239],"objective":[240],"increase":[246],"proportion":[248],"at":[258,279],"months":[260],"treatment.":[262],"At":[263],"significance":[265],"level":[266],"0.05,":[268],"minimum":[270],"43":[272],"achieve":[275],"power":[277],"least":[280],"80%":[281],"detect":[283],"improvement":[285],"(80%":[286],"vs":[287],"historical":[289],"control":[290],"60%),":[292],"using":[293],"two":[295],"sized":[296],"exact":[297],"binomial":[298],"test.":[299],"Additional":[300],"objectives":[301],"determining":[303,320,328],"number":[305],"greater":[309,326],"than":[310],"1":[312],"month":[317],"treatment,":[319],"rates":[321],"DFS":[329],"OS,":[331],"assess":[334],"patient":[335,350],"reported":[336],"outcomes":[337],"regarding":[338],"adverse":[339],"events.":[340],"opened":[343],"enrollment":[345],"12/21/2023.":[347],"was":[354],"enrolled":[355],"1/25/2024.":[356],"Clinical":[357],"information:":[359],"NCT06169371":[360],".":[361],"[Table:":[362],"see":[363],"text]":[364]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4399122002","counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2024-05-30T00:00:00"}
